PMC:7463108 / 53449-55481
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T523 | 44-47 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
T524 | 89-92 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
T525 | 149-154 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T526 | 155-160 | Body_part | denotes | brain | http://purl.org/sig/ont/fma/fma50801 |
T527 | 232-235 | Body_part | denotes | CNS | http://purl.org/sig/ont/fma/fma55675 |
T528 | 334-337 | Body_part | denotes | CNS | http://purl.org/sig/ont/fma/fma55675 |
T529 | 339-342 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
T530 | 363-366 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
T531 | 367-375 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T532 | 409-423 | Body_part | denotes | tight junction | http://purl.org/sig/ont/fma/fma67397 |
T533 | 424-432 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T534 | 869-886 | Body_part | denotes | endothelial cells | http://purl.org/sig/ont/fma/fma66772 |
T535 | 881-886 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T536 | 1059-1073 | Body_part | denotes | tight junction | http://purl.org/sig/ont/fma/fma67397 |
T537 | 1074-1082 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T538 | 1471-1479 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T539 | 1491-1503 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T540 | 1925-1933 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T100 | 149-168 | Body_part | denotes | blood-brain barrier | http://purl.obolibrary.org/obo/UBERON_0000120 |
T101 | 149-154 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T102 | 155-160 | Body_part | denotes | brain | http://purl.obolibrary.org/obo/UBERON_0000955 |
T103 | 232-235 | Body_part | denotes | CNS | http://purl.obolibrary.org/obo/UBERON_0001017 |
T104 | 334-337 | Body_part | denotes | CNS | http://purl.obolibrary.org/obo/UBERON_0001017 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T611 | 149-154 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T612 | 149-154 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T613 | 155-160 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
T614 | 155-160 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | brain |
T615 | 232-235 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | CNS |
T616 | 232-235 | http://www.ebi.ac.uk/efo/EFO_0000908 | denotes | CNS |
T617 | 232-235 | http://purl.obolibrary.org/obo/UBERON_0001017 | denotes | CNS |
T618 | 334-337 | http://www.ebi.ac.uk/efo/EFO_0000302 | denotes | CNS |
T619 | 334-337 | http://www.ebi.ac.uk/efo/EFO_0000908 | denotes | CNS |
T620 | 334-337 | http://purl.obolibrary.org/obo/UBERON_0001017 | denotes | CNS |
T621 | 415-423 | http://purl.obolibrary.org/obo/UBERON_0007651 | denotes | junction |
T622 | 869-886 | http://purl.obolibrary.org/obo/CL_0000115 | denotes | endothelial cells |
T623 | 1065-1073 | http://purl.obolibrary.org/obo/UBERON_0007651 | denotes | junction |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T77 | 311-315 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T66460 | 367-375 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T79 | 424-432 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T80 | 1074-1082 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T11026 | 1227-1235 | Chemical | denotes | morphine | http://purl.obolibrary.org/obo/CHEBI_17303|http://purl.obolibrary.org/obo/CHEBI_58097 |
T36538 | 1278-1286 | Chemical | denotes | morphine | http://purl.obolibrary.org/obo/CHEBI_17303|http://purl.obolibrary.org/obo/CHEBI_58097 |
T51283 | 1401-1409 | Chemical | denotes | morphine | http://purl.obolibrary.org/obo/CHEBI_17303|http://purl.obolibrary.org/obo/CHEBI_58097 |
T26096 | 1459-1463 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T88 | 1471-1479 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T30663 | 1491-1503 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T56470 | 1536-1544 | Chemical | denotes | morphine | http://purl.obolibrary.org/obo/CHEBI_17303|http://purl.obolibrary.org/obo/CHEBI_58097 |
T4369 | 1833-1841 | Chemical | denotes | morphine | http://purl.obolibrary.org/obo/CHEBI_17303|http://purl.obolibrary.org/obo/CHEBI_58097 |
T5483 | 1910-1914 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T96748 | 1925-1933 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T82380 | 2000-2005 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1983 | 1489-1503 | Gene | denotes | P-glycoprotein | Gene:5243 |
1984 | 1505-1509 | Gene | denotes | P-gp | Gene:5243 |
1985 | 1578-1582 | Gene | denotes | P-gp | Gene:5243 |
1986 | 1754-1758 | Gene | denotes | P-gp | Gene:5243 |
1987 | 44-47 | Species | denotes | HIV | Tax:12721 |
1988 | 89-92 | Species | denotes | HIV | Tax:12721 |
1989 | 339-342 | Species | denotes | HIV | Tax:12721 |
1990 | 1227-1235 | Chemical | denotes | morphine | MESH:D009020 |
1991 | 1278-1286 | Chemical | denotes | morphine | MESH:D009020 |
1992 | 1401-1409 | Chemical | denotes | morphine | MESH:D009020 |
1993 | 1536-1544 | Chemical | denotes | morphine | MESH:D009020 |
1994 | 1833-1841 | Chemical | denotes | morphine | MESH:D009020 |
1995 | 363-375 | Disease | denotes | HIV proteins | MESH:D015658 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T94 | 236-247 | http://purl.obolibrary.org/obo/GO_0042592 | denotes | homeostasis |
T95 | 380-389 | http://purl.obolibrary.org/obo/GO_0009056 | denotes | breakdown |
T96 | 1464-1470 | http://purl.obolibrary.org/obo/GO_0140352 | denotes | efflux |
T97 | 1464-1470 | http://purl.obolibrary.org/obo/GO_0140115 | denotes | efflux |
T98 | 1489-1503 | http://purl.obolibrary.org/obo/GO_0008559 | denotes | P-glycoprotein |
T99 | 1910-1924 | http://purl.obolibrary.org/obo/GO_0015893 | denotes | drug transport |
T100 | 1915-1924 | http://purl.obolibrary.org/obo/GO_0006810 | denotes | transport |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T744 | 0-175 | Sentence | denotes | Despite growing evidence on how opiates and HIV interact to impact the neuropathology of HIV, little is known about their interactive effects on the blood-brain barrier (BBB). |
T745 | 176-338 | Sentence | denotes | BBB integrity and function are critical for maintaining CNS homeostasis, and mediating neuroimmune interactions with the periphery and drug delivery into the CNS. |
T746 | 339-449 | Sentence | denotes | HIV and many individual HIV proteins can breakdown the BBB disrupting tight junction proteins (Dallasta et al. |
T747 | 450-468 | Sentence | denotes | 1999; Boven et al. |
T748 | 469-488 | Sentence | denotes | 2000; Andras et al. |
T749 | 489-509 | Sentence | denotes | 2003; Mahajan et al. |
T750 | 510-531 | Sentence | denotes | 2008; Banerjee et al. |
T751 | 532-551 | Sentence | denotes | 2010; Gandhi et al. |
T752 | 552-567 | Sentence | denotes | 2010; Xu et al. |
T753 | 568-586 | Sentence | denotes | 2012; Patel et al. |
T754 | 587-712 | Sentence | denotes | 2017) and decreasing transendothelial electrical resistance (TEER) (an in vitro measure of barrier integrity) (Mahajan et al. |
T755 | 713-732 | Sentence | denotes | 2008; Gandhi et al. |
T756 | 733-774 | Sentence | denotes | 2010; Mishra and Singh 2014; Patel et al. |
T757 | 775-902 | Sentence | denotes | 2017), with resultant paracellular “leakage” of compounds/current between compromised barrier endothelial cells (Mahajan et al. |
T758 | 903-922 | Sentence | denotes | 2008; Gandhi et al. |
T759 | 923-939 | Sentence | denotes | 2010; Wen et al. |
T760 | 940-959 | Sentence | denotes | 2011; McLane et al. |
T761 | 960-981 | Sentence | denotes | 2014; Leibrand et al. |
T762 | 982-994 | Sentence | denotes | 2017, 2019). |
T763 | 995-1130 | Sentence | denotes | Although opioids can also impair the BBB through alterations in tight junction proteins and/or increased paracellular flux (Baba et al. |
T764 | 1131-1151 | Sentence | denotes | 1988; Mahajan et al. |
T765 | 1152-1168 | Sentence | denotes | 2008; Wen et al. |
T766 | 1169-1190 | Sentence | denotes | 2011; Leibrand et al. |
T767 | 1191-1351 | Sentence | denotes | 2019), others have found that it is morphine withdrawal, not the continued exposure to morphine, that most greatly disrupts BBB integrity (Sharma and Ali 2006). |
T768 | 1352-1511 | Sentence | denotes | In addition to perturbing paracellular dynamics, morphine may also alter the expression and/or function of drug efflux proteins, such as P-glycoprotein (P-gp). |
T769 | 1512-1627 | Sentence | denotes | Sub-chronic and chronic morphine exposure is reported to increase P-gp expression and/or function (Aquilante et al. |
T770 | 1628-1648 | Sentence | denotes | 2000; Mahajan et al. |
T771 | 1649-1668 | Sentence | denotes | 2008; Yousif et al. |
T772 | 1669-1690 | Sentence | denotes | 2008; Leibrand et al. |
T773 | 1691-1697 | Sentence | denotes | 2019). |
T774 | 1698-1795 | Sentence | denotes | Alternatively, other investigators report no changes in P-gp with chronic exposure (Chaves et al. |
T775 | 1796-1867 | Sentence | denotes | 2016), while some see increases upon morphine withdrawal (Yousif et al. |
T776 | 1868-1887 | Sentence | denotes | 2012; Chaves et al. |
T777 | 1888-1894 | Sentence | denotes | 2016). |
T778 | 1895-2032 | Sentence | denotes | Alterations in drug transport proteins would impact the central accumulation and efficacy of therapeutic drugs that are their substrates. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32876803-10595922-62958107 | 450-454 | 10595922 | denotes | 1999 |
32876803-10931369-62958108 | 469-473 | 10931369 | denotes | 2000 |
32876803-22197032-62958109 | 568-572 | 22197032 | denotes | 2012 |
32876803-24965120-62958110 | 756-760 | 24965120 | denotes | 2014 |
32876803-21738771-62958111 | 940-944 | 21738771 | denotes | 2011 |
32876803-24629894-62958112 | 960-964 | 24629894 | denotes | 2014 |
32876803-28057474-62958113 | 982-986 | 28057474 | denotes | 2017 |
32876803-2841613-62958114 | 1131-1135 | 2841613 | denotes | 1988 |
32876803-21738771-62958115 | 1169-1173 | 21738771 | denotes | 2011 |
32876803-17105918-62958116 | 1345-1349 | 17105918 | denotes | 2006 |
32876803-10665989-62958117 | 1628-1632 | 10665989 | denotes | 2000 |
32876803-18761714-62958118 | 1669-1673 | 18761714 | denotes | 2008 |
32876803-26554626-62958119 | 1796-1800 | 26554626 | denotes | 2016 |
32876803-22845665-62958120 | 1868-1872 | 22845665 | denotes | 2012 |
32876803-26554626-62958121 | 1888-1892 | 26554626 | denotes | 2016 |